Taiwan Liposome Company, Ltd. total revenue, net income and dynamics of changes in Taiwan new dollar today
The dynamics of net revenue of Taiwan Liposome Company, Ltd. rose. The change amounted to 25 535 000 $. The dynamics of net revenue is shown in comparison with the previous report. Taiwan Liposome Company, Ltd. net income is now -201 369 000 $. The dynamics of Taiwan Liposome Company, Ltd. net income grew by 89 433 000 $ for the last reporting period. The financial report chart on our website displays information by dates from 31/03/2019 to 31/03/2021. Information on Taiwan Liposome Company, Ltd. net income on the chart on this page is drawn in blue bars. A graph of the value of all Taiwan Liposome Company, Ltd. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
The dates of the latest financial statements of Taiwan Liposome Company, Ltd.: 31/03/2019, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Taiwan Liposome Company, Ltd. for today is 31/03/2021. Gross profit Taiwan Liposome Company, Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Taiwan Liposome Company, Ltd. is 37 618 000 $
Total revenue Taiwan Liposome Company, Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Taiwan Liposome Company, Ltd. is 37 618 000 $ Operating income Taiwan Liposome Company, Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Taiwan Liposome Company, Ltd. is -216 203 000 $ Net income Taiwan Liposome Company, Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Taiwan Liposome Company, Ltd. is -201 369 000 $
Current assets Taiwan Liposome Company, Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Taiwan Liposome Company, Ltd. is 1 173 607 000 $ Total assets Taiwan Liposome Company, Ltd. refers to the total amount of assets owned by a person or entity. Total assets Taiwan Liposome Company, Ltd. is 1 509 396 000 $ Current cash Taiwan Liposome Company, Ltd. - the sum of all of the cash a company has on the date of report. Current cash Taiwan Liposome Company, Ltd. is 1 080 009 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
1 221 091 565.40 $
392 217 804.90 $
2 145 463 528.50 $
382 252 492.80 $
387 770 743.80 $
611 454 671.10 $
668 422 497.60 $
5 121 099 229.50 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
1 221 091 565.40 $
392 217 804.90 $
2 145 463 528.50 $
382 252 492.80 $
387 770 743.80 $
611 454 671.10 $
668 422 497.60 $
5 121 099 229.50 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-7 018 014 240.90 $
-9 687 971 296.80 $
-7 907 718 603.60 $
-8 329 053 297.60 $
-9 233 267 414.40 $
-5 819 807 187 $
-7 847 309 985.30 $
-3 640 974 470.10 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-6 536 498 150.70 $
-9 439 520 160.60 $
-7 585 744 887.90 $
-7 869 577 751.10 $
-8 956 965 340.80 $
-5 791 729 027.50 $
-7 838 383 402.80 $
-3 625 328 605.50 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
7 231 310 872.20 $
8 936 417 970.90 $
8 814 302 322.30 $
7 429 545 924.30 $
8 087 353 903.80 $
5 125 513 830.30 $
7 278 151 085.10 $
7 438 440 046.50 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
8 239 105 806.30 $
10 080 189 101.70 $
10 053 182 132.10 $
8 711 305 790.40 $
9 621 038 158.20 $
6 431 261 858.10 $
8 515 732 482.90 $
8 762 073 699.60 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
38 095 635 302.10 $
46 482 403 013.10 $
37 605 776 914.80 $
45 637 364 023.20 $
35 563 959 124.20 $
35 010 738 231.30 $
24 901 367 319.90 $
35 174 662 746.30 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
48 995 446 978.80 $
56 788 028 898.30 $
48 238 213 100.40 $
56 086 821 497.70 $
44 989 261 673.40 $
44 542 445 643.90 $
35 026 546 397.40 $
45 526 447 178.10 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
35 057 416 142.70 $
43 583 373 620.10 $
32 950 223 307.90 $
40 081 816 138.50 $
33 235 257 202.20 $
32 705 018 201.70 $
22 238 811 212.40 $
32 079 995 125.20 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
18 070 551 629.10 $
17 406 316 510.20 $
19 690 937 344.80 $
13 098 023 192.70 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
21 555 846 500.40 $
21 393 317 778.30 $
24 247 454 576.40 $
27 176 834 349.90 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
47.91 %
48.03 %
69.23 %
59.69 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
7 653 911 517.90 $
14 215 079 496.60 $
23 450 651 592.30 $
30 902 010 838.20 $
23 433 415 173 $
23 149 127 865.60 $
10 779 091 821 $
18 349 612 828.20 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-6 840 229 177.80 $
-5 836 946 225.40 $
-9 009 031 662 $
-3 553 688 723.40 $
Last revenue report of Taiwan Liposome Company, Ltd. was 31/03/2021. According to last financial report total revenue in Taiwan Liposome Company, Ltd. was 1 221 091 565.40 Taiwan new dollar and changed by -76.156% since last year. Net income in Taiwan Liposome Company, Ltd. was -6 536 498 150.70 $ in last quartal, net income changes to 0%.
